IMD business school for management and leadership courses

Thermo Fisher Scientific’s leadership, including the CEO and CIO, has recognized AI as a transformative force and backed this vision with action, such as appointing a Chief Data, Analytics & AI Officer within its Clinical Research group. AI is now embedded across the company’s products and operations. New offerings in 2025 include the Vulcan™ Automated Lab, which enhances semiconductor manufacturing, while machine learning is integrated into tools like cell counters and electron microscopes for faster, more accurate results. 

Internally, Thermo Fisher uses generative AI (GenAI) to improve workflows and decision-making through a secure enterprise platform. The company also prioritizes workforce readiness, introducing company-wide AI training and encouraging experimentation with AI tools. Ethical AI use is another focus: a Responsible AI framework and an AI Technology Council oversees compliance, security, and governance. 

Beyond internal efforts, Thermo Fisher is forming strategic partnerships to co-develop AI solutions in clinical trials and genetic medicine manufacturing. In November 2023, it formed a strategic partnership with Flagship Pioneering to create new platform companies focused on novel life-science tools and capabilities, with a focus on artificial intelligence.